News
In just a relatively short 25 years, the limited liability company (LLC) has become the entity-of-choice for nearly all purposes, with the almost singular...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow I’m an Equity Analyst and Accountant specializing in restaurant stocks, with a strong foundation in Business Administration and...
News
This article was written by Follow Investing in high-growth opportunities across industries, employing a value investing approach that prioritizes robust business models and strategic...
News
This article was written by Follow I’m a full time value investor and writer who enjoys using classical value ratios to pick my portfolio....
News
Rockwool A/S (OTCPK:RKWBF) Q3 2023 Earnings Call Transcript November 23, 2023 5:00 AM ET Company Participants Thomas Harder – Director, Group Treasury & IR...
News
Navigating the insurance landscape following a cancer diagnosis presents a unique set of challenges and concerns. Patients and their families often find themselves at...
News
It has been an eventful two months since I last updated Unity Software Inc. (NYSE:U) investors in mid-September. The debacle surrounding the company’s disastrous...
News
Fidelis Insurance Holdings Limited (NYSE:FIHL) Q3 2023 Earnings Call Transcript November 21, 2023 8:00 AM ET Company Participants Jillian Benson – Group Head of...
News
As everyone knows, Monster Beverage (NASDAQ:MNST) has been a stock that has given spectacular returns to its shareholders so far for decades. It has...
News
If you’re like me, you rarely transact in cash anymore. I can probably count on one hand how many times I use physical cash...
News
Elevator Pitch I stick with my Hold rating for Cushman & Wakefield plc (NYSE:CWK) shares. With my previous article for CWK published on September...
News
Currently I am covering the biggest airplane manufacturers in the world. I am also covering various airlines and lessors that are the customers for...
News
BiomX logo (BiomX website) BiomX Inc. (NYSE:PHGE) is a clinical-stage biotech company that develops bacteriophage (“phage”) cocktails to treat various diseases utilizing its next-generation...
